|
KMID : 0614720140570050419
|
|
Journal of Korean Medical Association
2014 Volume.57 No. 5 p.419 ~ p.426
|
|
|
Periprocedural antithrombotic management
|
|
Joo Jin
|
|
|
Abstract
|
|
|
|
The periprocedural management of patients on long-term antithrombotic therapy (antiplatelet agents or vitamin K antagonists) who may require temporary disruption, given that an invasive procedure is always a dilemma for clinicians. Discontinuation of antithrombotic therapy can place patients at an increased risk of thromboembolic complications while the continuation of antithrombotic therapy can increase the procedure-related bleeding risk. Therefore, it is imperative for clinicians to be proficient in making thoughtful and individualized decisions on the appropriate management of periprocedural anticoagulants, drawing from recent evidence-based guidelines.
|
|
|
KEYWORD
|
|
|
Antithrombotic therapy, Antiplatelet therapy, Bridging therapy, Heparin, Vitamin K antagonist
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|